ArticlePharmacology research & perspectives2024

An open-label study to explore the optimal design of CYP3A drug-drug interaction clinical trials in healthy Chinese people.

Jingcheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.